14.2% Return Seen to Date on SmarTrend Vascular Solutions Call (VASC)
Comtex SmarTrend(R) - Fri May 09, 9:57AM CDT
SmarTrend identified a Downtrend for Vascular Solutions (NASDAQ:VASC) on April 10th, 2014 at $24.12. In approximately 4 weeks, Vascular Solutions has returned 14.20% as of today's recent price of $20.69.
Vascular Solutions Down 11.5% Since SmarTrend Downtrend Call (VASC)
Comtex SmarTrend(R) - Fri May 02, 9:33AM CDT
SmarTrend identified a Downtrend for Vascular Solutions (NASDAQ:VASC) on April 10th, 2014 at $24.12. In approximately 3 weeks, Vascular Solutions has returned 11.47% as of today's recent price of $21.35.
What Makes Vascular Solutions (VASC) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:54AM CDT
Vascular Solutions (VASC) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter as well as the current year.
Vascular Solutions to Participate in Bank of America Merrill Lynch 2014 Health Care Conference
GlobeNewswire - Thu May 01, 3:12PM CDT
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2014 Health Care Conference being held at The Encore at Wynn Hotel in Las Vegas.
Vascular Solutions Reports First Quarter Results
GlobeNewswire - Tue Apr 22, 3:19PM CDT
-- Record revenues increase 15% to $29.9 million, reflecting growth in all three product categories
Vascular Solutions Enters Into Agreement With U.S. Army to Develop Freeze-Dried Plasma Product
GlobeNewswire - Tue Apr 22, 3:19PM CDT
- U.S. Army will sponsor, conduct and fund all Food and Drug Administration (FDA) required pre-clinical and clinical studies of the freeze-dried plasma product developed by Vascular Solutions
Injunction Lifted on Boston Scientific's Guidezilla - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 5:50PM CDT
Boston Scientific's Guidezilla guide extension catheter gets freed of an injunction by the U.S. Court of Appeals for the Federal Circuit.
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Vacated by Federal Circuit
GlobeNewswire - Tue Apr 15, 10:51AM CDT
Vascular Solutions, Inc. (Nasdaq:VASC) announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the preliminary injunction that was previously issued by the District Court for the District of Minnesota effective January 13, 2014 against Boston Scientific's Guidezilla guide extension catheter. In its one paragraph opinion vacating the injunction, the Court noted that a preliminary injunction is a "drastic and extraordinary remedy that is not to be routinely granted" and "at this stage of the case the record is too incomplete . . . to warrant the grant of a preliminary injunction."
Vascular Solutions Surpasses 50,000 Successfully Reprocessed ClosureFAST(R) Catheters
GlobeNewswire - Wed Apr 09, 3:05PM CDT
-- Reprocessing of popular vein treatment catheter results in significant cost savings and reduced medical waste for U.S. vein clinics
Vascular Solutions, Inc. to Webcast First Quarter Conference Call
GlobeNewswire - Tue Apr 08, 3:05PM CDT
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its first quarter conference call on Tuesday, April 22nd at 3:30pm CDT. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's first quarter results. The company will issue an earnings news release after market close on Tuesday, April 22nd.
Physician Reports Positive 12-Month Clinical Experience and Cost Savings From Use of Reprocessed ClosureFAST(R) Catheters
GlobeNewswire - Wed Feb 19, 3:30PM CST
-- Dr. James Isobe presented data today at the American Venous Forum annual meeting in New Orleans reflecting his experience using Vascular Solutions' reprocessing service for ClosureFAST catheters.
8-K: VASCULAR SOLUTIONS INC
Edgar Online - Tue Feb 04, 11:07PM CST
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Vascular Solutions Reports Record Fourth Quarter Results
GlobeNewswire - Tue Feb 04, 9:49PM CST
-- Q4 revenue increased 15% to a record quarterly level of $29.1 million, exceeding the top end of guidance
Vascular Solutions Launches ThrombiDisc(TM) Topical Hemostat in U.S.
GlobeNewswire - Tue Jan 21, 8:00AM CST
- Novel thrombin-based topical hemostat controls bleeding from vascular access sites
Teekay Offshore Completes Norwegian Bond Issuance
Marketwire Canada - Tue Jan 14, 9:09AM CST
Teekay Offshore Partners L.P. (Teekay Offshore or the Partnership) (NYSE:TOO) announces that it has issued NOK 1,000 million in senior unsecured bonds, maturing in January 2019, in the Norwegian bond market. The aggregate principal amount of the bonds is equivalent to approximately 165 million U.S. dollars (USD). The bond offering was significantly oversubscribed. The proceeds of the bonds are expected to be used for general partnership purposes. Teekay Offshore will apply for listing of the bonds on the Oslo Stock Exchange.
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Becomes Effective
GlobeNewswire - Mon Jan 13, 8:03AM CST
Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. Court of Appeals for the Federal Circuit has refused to grant an interim stay during appeal of the injunction issued by the District Court for the District of Minnesota against Boston Scientific's Guidezilla guide extension catheter, thereby causing the injunction to take effect starting January 13, 2014.
Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call
GlobeNewswire - Tue Jan 07, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its fourth quarter conference call on Tuesday, February 4th at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's fourth quarter results. The company will issue an earnings news release after market close on Tuesday, February 4th.
Vascular Solutions Receives Shonin Approvals to Launch GuideLiner(R) Catheter and SuperCross(TM) FT Microcatheter in Japan
GlobeNewswire - Wed Dec 11, 3:05PM CST
-- Both devices also receive reimbursement designation from the Japanese Ministry of Health, Labour and Welfare
Vascular Solutions Granted Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter
GlobeNewswire - Mon Dec 09, 5:02PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) announced today that the U.S. District Court for the District of Minnesota has granted Vascular Solutions' request for a preliminary injunction against Boston Scientific's Guidezilla guide extension catheter.
Shares of VASC Up 33.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 29, 9:32AM CST
SmarTrend identified an Uptrend for Vascular Solutions (NASDAQ:VASC) on July 16th, 2013 at $15.81. In approximately 5 months, Vascular Solutions has returned 33.82% as of today's recent price of $21.15.